1. Home
  2. ASNS vs AZTR Comparison

ASNS vs AZTR Comparison

Compare ASNS & AZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actelis Networks Inc.

ASNS

Actelis Networks Inc.

HOLD

Current Price

$0.19

Market Cap

1.9M

ML Signal

HOLD

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.17

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASNS
AZTR
Founded
1998
2014
Country
United States
United States
Employees
N/A
12
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
1.9M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
ASNS
AZTR
Price
$0.19
$0.17
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
683.3K
1.5M
Earning Date
01-01-0001
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
67.43
5.06
EPS
N/A
N/A
Revenue
$7,760,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$171.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
38.42
N/A
52 Week Low
$0.18
$0.14
52 Week High
$3.63
$1.40

Technical Indicators

Market Signals
Indicator
ASNS
AZTR
Relative Strength Index (RSI) 27.21 30.94
Support Level N/A $0.15
Resistance Level $0.62 $0.32
Average True Range (ATR) 0.02 0.02
MACD 0.01 0.00
Stochastic Oscillator 14.01 20.12

Price Performance

Historical Comparison
ASNS
AZTR

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

Share on Social Networks: